LexDanaLexDanabeta
Inventor

Oliver Nayler

Inventor
Arlesheim, CH

Overview

40→
Patents
2004–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 40 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes28%
C07KPeptides2%
C12NMicroorganisms or enzymes2%
PatentTitleYear
10,660,880Dosing regimen for a selective S1P202010,251,867Dosing regimen for a selective S1P201910,189,839Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase20199,765,092'Tricyclic piperidine compounds'20179,617,250'Pyridin-4-yl derivatives'20179,133,179'2-methoxy-pyridin-4-yl-derivatives'20159,000,018'Thiazolidin-4-one-derivatives'2015RE045174'Thiazolidin-4-one derivatives'20148,785,484'Dosing regimen for a selective S1P1 receptor agonist'20148,697,732'Pyridine derivatives'20148,658,675'Pyridin-4-yl derivatives'20148,598,208'Pyridine derivatives as S1P1/EDG1 receptor modulators'20138,592,460'Amino-pyridine derivatives as S1P1 /EDG1 receptor agonists'20138,580,824'Pyridin-4-yl derivatives as immunomodulating agents'20138,575,200'Pyridin-2-yl derivatives as immunomodulating agents'20138,524,752'Thiazolidin-4-one derivatives'20138,410,151'Aminomethyl benzene derivatives'2013RE043833'Thiazolidin-4-one derivatives'20128,299,086'Pyrimidine derivatives'20128,288,554'Pyridin-3-yl derivatives as immunomodulating agents'2012RE043728'Thiazolidin-4-one derivatives'20128,273,779'Thiazolidin 4-one derivatives'20128,178,562'Pyridine derivatives'20128,148,410'Thiophene derivatives as agonists of S1P1/EDG1'20128,133,910'Thiophene derivatives as S1P1/EDGE1 receptor agonists'20128,044,076'Phenyl derivatives and their use as immunomodulators'20118,039,644'Hydrogenated benzo (C) thiophene derivatives as immunomodulators'20118,003,800'Thiophene derivatives as S1P1/EDG1 receptor agonists'20117,981,924'Thiophene derivatives'20117,875,726'Thiazolidin-4-one derivatives'20117,846,964'Thiophene derivatives as spingosine-1-phosphate-1 receptor agonists'20107,750,040'Thiophene derivatives'20107,723,378'Hydrogenated benzo (C) thiophene derivatives as immunomodulators'20107,626,037'Thiazolidin-4-one derivatives'20097,605,269'Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists'20097,435,828'Thiazolidin-4-one derivatives'20087,375,227'Quinoline derivatives'20087,074,589'Nucleic acids encoding BDP-1'20066,815,451'1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists'20046,797,513'Nucleic acid encoding CLK2 protein kinases'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2020Patents assigned to ACTELION PHARMACEUTICALS LTD (38)· patent assignee history
2004–2020Based in Arlesheim, CH· patent location history
2004Based in Graefehing, DE· patent location history
2006Based in Martinsried, DE· patent location history
2012–2015Patents assigned to NAYLER OLIVER (18)· patent assignee history
2012–2015Patents assigned to BOLLI MARTIN (17)· patent assignee history
2012–2015Patents assigned to MATHYS BORIS (17)· patent assignee history
2012–2015Patents assigned to MUELLER CLAUS (17)· patent assignee history
2014–2019Based in Allschwil, CH· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ACTELION PHARMACEUTICALS LTD382004–2020
NAYLER OLIVERself182012–2015
BOLLI MARTIN172012–2015
MATHYS BORIS172012–2015
MUELLER CLAUS172012–2015
Locations
LocationPatentsSpan
Arlesheim, CH332004–2020
Allschwil, CH52014–2019
Martinsried, DE12006
Graefehing, DE12004